New Immunotherapies Are Aim of Pfizer-Adaptive Technologies Partnership
News
Pfizer, Inc., and Adaptive Biotechnologies Corporation have announced a translational research collaboration to advance next-generation sequencing of the adaptive immune system. Specifically, the companies want combine drug development and platform technology biomarker expertise ... Read more